Medpace Holdings, Inc. (MEDP) Guidance & Earnings Results

On 2026-10-21 Medpace Holdings, Inc. raised guidance: "FY2026 revenue $2.835-2.855B (12.0-12.8% growth); GAAP net income $514-524M; EBITDA $638-652M; diluted EPS…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason

MEDPMedpace Holdings, Inc.Follow MEDP — free

Diagnostics & Research · Healthcare

—

Price chart with a free account

Market cap: 18.7B
P/E TTM: 37.2
Dividend yield: —
52-week: —
Next earnings: 8 Feb, in 107 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
21 Oct 26	Raised	FY2026 revenue $2.835-2.855B (12.0-12.8% growth); GAAP net income $514-524M; EBITDA $638-652M; diluted EPS $17.97-18.32 · full year
22 Jul 26	Raised	FY2026 revenue $2.805-2.885B (growth 10.9-14.0% over FY2025 $2.530B); GAAP net income $494-514M; EBITDA $618-642M; diluted EPS $17.25-17.95; tax rate 19.0-19.5%; interest income $21.1M; 28.6M diluted shares · full year
22 Apr 26	Raised	FY2026 revenue guidance $2.755B-$2.855B (8.9%-12.8% growth), GAAP net income $487M-$511M, EBITDA $605M-$635M, diluted EPS $16.68-$17.50 · full year
9 Feb 26	Raised	2026 revenue guidance $2.755B-$2.855B (8.9%-12.8% growth) · full year
22 Oct 25	Raised	FY2025 revenue guidance $2.48-2.53B (17.6-20.0% growth), EBITDA $545-555M, net income $431-439M, EPS $14.60-14.86 · full year

Medpace Holdings, Inc. — questions

What guidance did Medpace Holdings, Inc. give?: On 2026-10-21: "FY2026 revenue $2.835-2.855B (12.0-12.8% growth); GAAP net income $514-524M; EBITDA $638-652M; diluted EPS $17.97-18.32"
When does Medpace Holdings, Inc. report earnings?: Medpace Holdings, Inc.'s next earnings report is expected on 2027-02-08.

Every figure on this page comes from Medpace Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.